Insulin and vanadium protect against osteoarthritis development secondary to diabetes mellitus in rats

Archives of Physiology and Biochemistry

Volumn 122, Issue 3, 2016, Pages 148-154

  El Karib, Abbas O ^a   Al Ani, Bahjat ^a   Al Hashem, Fahaid ^a   Dallak, Mohammad ^a   Bin Jaliah, Ismaeel ^a   El Gamal, Basiouny ^a   Bashir, Salah O ^a   Eid, Refaat A ^b   Haidara, Mohamed A ^a,c  

^a Department of Physiology ^*  (Saudi Arabia)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Diabetes; insulin; osteoarthritis; rat model; T1DM; vanadium

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN; TRACE ELEMENT; VANADIUM;

ANIMAL; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HYPOGLYCEMIC AGENTS; INSULIN; MALE; OSTEOARTHRITIS; RATS; RATS, SPRAGUE-DAWLEY; TRACE ELEMENTS; VANADIUM;

EID: 84971384437     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2016.1159698     Document Type: Article

References (44)

1. M.A.Atkinson, G.S.Eisenbarth, A.W.Michels. (2014). Type 1 diabetes. Lancet, 383:69–82
2. H.Bliddal, R.Christensen. (2009). The treatment and prevention of knee osteoarthritis: A tool for clinical decision-making. Expert Opin Pharmacother, 10:1793–804
3. L.Cai, F.W.Okumu, J.L.Cleland,. (2002). A slow release formulation of insulin as a treatment for osteoarthritis. Osteoarthr Cartil, 10:692–706
4. M.C.Cam, W.M.Li, J.H.McNeill. (1997). Partial preservation of pancreatic beta-cells by vanadium: Evidence for long-term amelioration of diabetes. Metabolism, 46:769–78
5. G.Danaei, M.M.Finucane, Y.Lu,. (2011). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: Systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet, 378:31–40
6. F.Doss, J.Menard, M.Hauschild,. (2007). Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells. Scand J Rheumatol, 36:136–9
7. A.O.El Karib. (2014). Exercise ameliorates diabetes-induced osteoarthritis in rats. Egypt Acad J Biolog Sci, 6:93–9
8. K.Fuller, C.Murphy, B.Kirstein,. (2002). TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology, 143:1108–18
9. P.Gaede, H.Lund-Andersen, H.H.Parving, O.Pedersen. (2008). Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med, 358:580–91
10. S.Grazio, D.Balen. (2009). [Obesity: Risk factor and predictor of osteoarthritis]. Lijec Vjesn, 131:22–6
11. K.Gruzewska, A.Michno, T.Pawelczyk, H.Bielarczyk. (2014). Essentiality and toxicity of vanadium supplements in health and pathology. J Physiol Pharmacol, 65:603–11
12. J.M.Gutteridge. (1995). Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem, 41:1819–28
13. M.A.Haidara, A.S.Assiri, M.A.Youssef,. (2015). Differentiated mesenchymal stem cells ameliorate cardiovascular complications in diabetic rats. Cell Tissue Res, 359:565–75
14. M.A.Haidara, A.O.El Karib, I.Bin-Jaliah. (2014). The impact of vanadium on endothelial dysfunction in type 2 diabetic rats: Histological insight. Egypt Acad J Biol Sci C Physiol Mol Biol, 6:83–91
15. M.A.Haidara, H.Khloussy, H.Ammar, L.A.Aal Kassem. (2004). Impact of alpha-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes. Med Sci Monit, 10:BR41–6
16. C.Hamann, S.Kirschner, K.P.Gunther, L.C.Hofbauer. (2012). Bone, sweet bone – Osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol, 8:297–305
17. T.Hayami. (2008). [Osteoarthritis of the knee joint as a cause of musculoskeletal ambulation disability symptom complex (MADS)]. Clin Calcium, 18:1574–80
18. M.Janghorbani, R.M.Van Dam,, W.C.Willett, F.B.Hu. (2007). Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol, 166:495–505
19. M.Kapoor, J.Martel-Pelletier, D.Lajeunesse,. (2011). Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol, 7:33–42
20. S.Karmaker, T.K.Saha, Y.Yoshikawa, H.Sakurai. (2007). Amelioration of hyperglycemia and metabolic syndromes in type 2 diabetic KKA(y) mice by poly(gamma-glutamic acid)oxovanadium(IV) complex. ChemMedChem, 2:1607–12
21. I.Korczowska, J.K.Lacki. (2005). [Changes in certain biochemical markers of bone turnover in rheumatoid arthritis patients treated with short-term low dose glucocorticosteroids]. Przegl Lek, 62:1384–6
22. S.Kou, Y.Wu. (2014). Meta-analysis of tumor necrosis factor alpha -308 polymorphism and knee osteoarthritis risk. BMC Musculoskelet Disord, 15:373
23. M.C.Laiguillon, A.Courties, X.Houard,. (2015). Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthr Cartil, 23:1513--22
24. G.Livshits, G.Zhai, D.J.Hart,. (2009). Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study. Arthritis Rheum, 60:2037–45
25. N.Marty, M.Dallaporta, B.Thorens. (2007). Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda), 22:241–51
26. E.Molinar-Toribio, J.Perez-Jimenez, S.Ramos-Romero,. (2014). Cardiovascular disease-related parameters and oxidative stress in SHROB rats, a model for metabolic syndrome. PLoS One, 9:e104637
27. G.Musumeci, P.Castrogiovanni, R.Leonardi,. (2014). New perspectives for articular cartilage repair treatment through tissue engineering: A contemporary review. World J Orthop, 5:80–8
28. P.Narendran, E.Estella, S.Fourlanos. (2005). Immunology of type 1 diabetes. QJM, 98:547–56
29. F.U.Niethard. (1986). [Morphological and biochemical studies of the cartilage in the diabetic rat–a model for metabolism-induced arthritis]. Z Orthop Ihre Grenzgeb, 124:125–39
30. R.C.Pires, E.E.Souza, E.C.Vanzela,. (2014). Short-term calorie restriction improves glucose homeostasis in old rats: Involvement of AMPK. Appl Physiol Nutr Metab, 39:895–901
31. L.Pirmoradi, M.T.Mohammadi, A.Safaei,. (2014). Does the relief of glucose toxicity act as a mediator in proliferative actions of vanadium on pancreatic islet beta cells in streptozocin diabetic rats? Iran Biomed J, 18:173–80
32. P.Pottie, N.Presle, B.Terlain,. (2006). Obesity and osteoarthritis: More complex than predicted! Ann Rheum Dis, 65:1403–5
33. A.Pugliese. (2004). Genetics of type 1 diabetes. Endocrinol Metab Clin North Am, 33:1–16, vii
34. G.Schett, A.Kleyer, C.Perricone,. (2013). Diabetes is an independent predictor for severe osteoarthritis: Results from a longitudinal cohort study. Diabetes Care, 36:403–9
35. J.J.Senn, P.J.Klover, I.A.Nowak, R.A.Mooney. (2002). Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 51:3391–9
36. Y.Shechter, J.Li, J.Meyerovitch,. (1995). Insulin-like actions of vanadate are mediated in an insulin-receptor-independent manner via non-receptor protein tyrosine kinases and protein phosphotyrosine phosphatases. Mol Cell Biochem, 153:39–47
37. S.E.Shoelson, J.Lee, A.B.Goldfine. (2006). Inflammation and insulin resistance. J Clin Invest, 116:1793–801
38. C.Southern, D.Schulster, I.C.Green. (1990). Inhibition of insulin secretion from rat islets of Langerhans by interleukin-6. An effect distinct from that of interleukin-1. Biochem J, 272:243–5
39. A.K.Srivastava, M.Z.Mehdi. (2005). Insulino-mimetic and anti-diabetic effects of vanadium compounds. Diabet Med, 22:2–13
40. O.Stannus, G.Jones, F.Cicuttini,. (2010). Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartil, 18:1441–7
41. M.D.Van Manen, J.Nace, M.A.Mont. (2012). Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc, 112:709–15
42. T.P.Wycherley, P.M.Clifton, M.Noakes, G.D.Brinkworth. (2014). Weight loss on a structured hypocaloric diet with or without exercise improves emotional distress and quality of life in overweight and obese patients with type 2 diabetes. J Diabetes Investig, 5:94–8
43. W.Yan, X.Li. (2013). Impact of diabetes and its treatments on skeletal diseases. Front Med, 7:81–90
44. R.Yanardag, O.Ozsoy-Sacan, S.Bolkent,. (2005). Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum Exp Toxicol, 24:129–35